Synergistic mechanisms of ferroptosis in anaplastic thyroid cancer induced by dihydroartemisinin and sorafenib
	    		
		   		
		   			 
		   		
	    	
    	 
    	10.3760/cma.j.cn311282-20221223-00707
   		
        
        	
        		- VernacularTitle:双氢青蒿素和索拉非尼诱导未分化甲状腺癌铁死亡的协同机制
- Author:
	        		
		        		
		        		
			        		Jiayue DONG
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Shujie LI
			        		
			        		;
		        		
		        		
		        		
			        		Yan WANG
			        		
			        		;
		        		
		        		
		        		
			        		Lei YANG
			        		
			        		;
		        		
		        		
		        		
			        		Dihua LI
			        		
			        		;
		        		
		        		
		        		
			        		Zhaowei MENG
			        		
			        		
		        		
		        		
		        		
    Author Information Author Information
 
			        		
			        		
			        			1. 天津医科大学总医院核医学科 300052
 
 
- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Dihydroartemisinin;
			        		
			        		
			        		
				        		Sorafenib;
			        		
			        		
			        		
				        		Anaplastic thyroid cancer;
			        		
			        		
			        		
				        		Ferroptosis;
			        		
			        		
			        		
				        		Synergistic effect
			        		
			        		
	        			
        			
        		
- From:
	            		
	            			Chinese Journal of Endocrinology and Metabolism
	            		
	            		 2023;39(7):596-604
	            	
            	
- CountryChina
- Language:Chinese
- 
		        	Abstract:
			       	
			       		
				        
				        	Objective:To investigate the synergistic effects and molecular mechanisms of dihydroartemisinin(DHA) and sorafenib(SOR) in inducing ferroptosis in anaplastic thyroid cancer(ATC) cells.Methods:CCK-8 and flow cytometry assays were performed to detect the effects of DHA and SOR on the proliferation and ferroptosis of ATC cells(CAL-62). Real-time fluorescence quantitative PCR and Western blotting assays were performed to detect the expressions of ferroptosis-related genes glutathione peroxidase 4(GPX4), solute carrier family 7 member 11 gene(SCL7A11), lipoxygenase-15(LOX-15), and p53. The levels of iron death intermediate metabolites including lactate dehydrogenase(LDH), glutathione(GSH), malondialdehyde(MDA), ferrous ion(Fe 2+ ), nitric oxide(NO), and reactive oxygen species(ROS)were measured by corresponding assay kits. The corresponding inhibition of DHA and SOR on ATC in vivo was analyzed in a tumor model in nude mice. Results:Compared with the control group, DHA, SOR, and DHA+ SOR treatment significantly inhibited cell proliferation and apoptosis in a dose-dependent manner( P<0.001), with increased LDH, Fe 2+, MDA, and ROS contents and reduced GSH activity( P<0.001), which were promoted by ferrous sulfate(FeSO 4)and reversed by ferroptosis inhibitor-1. Compared with the control group and the drug monotherapy group, 15-LOX-2 and p53 expressions were upregulated in DHA+ SOR group while GPX4 and SCL7A11 expressions were decreased( P<0.001), without significant difference in 15-LOX-1 protein content. In addition, NO level was significantly increased in DHA+ SOR group( P<0.001). DHA and SOR inhibited tumor growth of ATC in vivo. Conclusion:DHA and SOR synergistically induced ferroptosis via upregulating the expression of 15-LOX-2 gene and inhibiting NO synthesis in ATC cells.